Prospective Multicenter Validation of a Simple Blood Test for the Diagnosis of Glut1 Deficiency Syndrome

Archive ouverte

Mochel, Fanny | Gras, Domitille | Luton, Marie-Pierre | Nizou, Manon | Giovannini, Donatella | Delattre, Caroline | Aubart, Mélodie | Barth, Magalie | de Saint-Martin, Anne | Doummar, Diane | Essid, Nouha | Garros, Alexa | Le Camus, Caroline Hachon | Hoebeke, Celia | The Tich, Sylvie Nguyen | Perivier, Maximilien | Rivera, Serge | Rolland, Anne | Roubertie, Agathe | Sarret, Catherine | Sevin, Caroline | Ville, Dorothée | Sitbon, Marc | Costa, Jean-Marc | Pons, Roser | Garcia-Cazorla, Angels | Vuillaumier, Sandrine | Petit, Vincent | Boespflug-Tanguy, Odile | de Vivo, Darryl, C | An, Isabelle | Bailly, Laurent | Bendetowicz, David | Charles, Perrine | Delorme, Cécile | Demeret, Sophie | Giron, Camille | Heide, Solveig | Heinzmann, Anna | Lalaude, Mathilde | Méneret, Aurélie | Mezouar, Nicolas | Monin, Marie-Lorraine | Mouthon, Linda | Roze, Emmanuel | Tarrano, Clément | Villain, Nicolas | Yazbeck, Elise | Auvin, Stéphane | Da Costa, Lydie | Dozières, Blandine | Portes, Vincent Des | Gokce-Samar, Zeynep | Panagiotakaki, Eleni | Souci, Sabrine | Toulouse, Joseph | Bellesme, Céline | Maurey, Hélène | Salah, Lucie | de Villemeur, Thierry Billette | Garzon, Pauline | Héron, Bénédicte | Isapof, Arnaud | Nougues, Marie-Christine | Ravelli, Claudia | Renaldo, Florence | Rodriguez, Diana | Valence, Stéphanie | Dangles, Marie-Thérèse | de Lonlay, Pascale | Desguerre, Isabelle | Durrleman, Chloé | Hully, Marie | Albertini, Francesca | Cano, Aline | Chabrol, Brigitte | Chavany, Julie | Kaphan, Elsa | Lagarde, Stanislas | Villeneuve, Nathalie | Avez-Couturier, Justine | Chaton, Laurence | Cuvellier, Jean-Christophe | Dehak, Rabha | Ballay, Florence Flamein | Floret, Valentine | Remérand, Ganaëlle | Abi Warde, Marie-Thérèse | Anheim, Mathieu | de Feraudy, Yvan | Gebus, Odile | Perriard, Caroline | Spitz, Marie-Aude | Khalil, Mirna | Tosi, Cécilia Marelli | Alvarez, Blanca Mercedes | Meyer, Pierre | Valle, Sarai Urtiaga | Canon, Mathilde | Ioos, Christine | Espil, Caroline | Husson, Marie | Goizet, Cyril | Michaud, Vincent | Pedespan, Jean-Michel | Damaj, Léna | Hadjadj, Sarah | Lavillaureix, Alinoë | Lepage, Jean-Marie | Ugolin, Mélissa | Froget, Rachel | Laroche, Cécile | Cancès, Claude | Salel, Yu Jin | Viguier, Agnès | Mazzola, Laure | Perrin, Laurine | Besson, Gérard | Dubois, Fanny | Lametery, Elodie | Jacquet, Coralie | de Pontual, Loïc | Castelnau, Pierre | Lagrue, Emmanuelle | Gibaud, Marc | Chouchane, Mondher | Darmency, Véronique | Fatus, Clémence Fauconnier | Bilbault, Claire | Cullier, Anne Charlotte | Mekary, Jacinthe | Touhami, Jawida | Baer, Marie-Elodie | Litou, Nadine | Samaan, Simon | Béesau, Christophe | Bitaudeau, Floriane | Cousin, Christelle | Desport, Elodie | Djouadi, Lynda | Hamadi, Yasmine | Lebreton, Emeline | Moriceau, Sandra

Edité par CCSD ; American Academy of Neurology -

International audience. Background and Objective GLUT1 deficiency syndrome (Glut1DS) is a treatable neurometabolic disease that causes a wide range of neurologic symptoms in children and adults. However, its diagnosis relies on an invasive test, that is, a lumbar puncture (LP) to measure glycorrhachia, and sometimes complex molecular analyses of the SLC2A1 gene. This procedure limits the number of patients able to receive the standard of care. We wished to validate the diagnostic performance of METAglut1, a simple blood test that quantifies GLUT1 on the erythrocyte surface. Methods We performed a multicenter validation study in France, involving 33 centers. We studied 2 patient cohorts: a prospective cohort consisting of patients with a clinical suspicion of Glut1DS explored through the reference strategy, that is, LP and analyses of the SLC2A1 gene, and a retrospective cohort that included patients previously diagnosed with Glut1DS. All patients were blind-tested with METAglut1. Results We analyzed 428 patients in the prospective cohort, including 15 patients newly diagnosed with Glut1DS, and 67 patients in the retrospective cohort. METAglut1 was 80% sensitive and >99% specific for the diagnosis of Glut1DS. Concordance analyses showed a substantial agreement between METAglut1 and glycorrhachia. In the prospective cohort, the positive predictive value of METAglut1 was slightly higher than that of glycorrhachia. METAglut1 succeeded to identify patients with Glut1DS with SCL2A1 mosaicism and variants of unknown significance.

Suggestions

Du même auteur

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome

Archive ouverte | Gras, Domitille | CCSD

International audience. Glucose transporter type 1 (GLUT1) deficiency syndrome (GLUT1‐DS) leads to a wide range of neurological symptoms. Ketogenic diets are very efficient to control epilepsy and movement disorders...

Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.

Archive ouverte | Milh, Mathieu | CCSD

International audience. BACKGROUND: Early onset epileptic encephalopathies (EOEEs) are dramatic heterogeneous conditions in which aetiology, seizures and/or interictal EEG have a negative impact on neurological deve...

Chargement des enrichissements...